Marc F. Pelletier
Algemeen Directeur bij GARDINER HEALTHCARE ACQUISITIONS CORP.
Oorsprong van het eerstegraads netwerk van Marc F. Pelletier
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Private Company | Financial Conglomerates | 12 | |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH.
8
| Holding Company | Biotechnology | 8 |
Iridia, Inc.
 Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Gardiner Founder LLC
4
| Private Company | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Marc F. Pelletier via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Compliance Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Linde, Inc. (Connecticut)
 Linde, Inc. (Connecticut) Chemicals: SpecialtyProcess Industries Linde, Inc. engages in design, engineering, manufacturing, and building of equipment that produces and distributes industrial gases. The company was founded in 1907 and is headquartered in Danbury, CT. | Chemicals: Specialty | Corporate Officer/Principal | |
Connecticut Innovations, Inc.
 Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
| STONERIDGE, INC. | Auto Parts: OEM | Director/Board Member | |
| PRUDENTIAL FINANCIAL, INC. | Life/Health Insurance | Director/Board Member | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| BIOASIS TECHNOLOGIES INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Lunewave, Inc.
 Lunewave, Inc. Computer CommunicationsElectronic Technology Lunewave, Inc. develops antenna and sensor technology designed for autonomous driving applications, wireless communications and drones. Its products include W-BAND, KA-BAND and X-BAND lenses. The company was founded by John Xin, Sherry Byon, Min Liang and Hao Xin in 2017 and is headquartered in Tucson, AZ. | Computer Communications | Consultant / Advisor | |
Propel(x), Inc.
 Propel(x), Inc. Packaged SoftwareTechnology Services Propel(x), Inc. operates an online platform for investing in technology startups. The company was founded by Swati Chaturvedi and Lisheng Wang in 2013 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Zenture Capital Partners, Inc.
 Zenture Capital Partners, Inc. Investment ManagersFinance Zenture Capital Management LLC (Zenture Capital Partners) is a venture capital firm founded in 1900. The firm is headquartered in Avon, Connecticut. | Investment Managers | Private Equity Investor | |
| University of South Florida | College/University | Undergraduate Degree | |
AnaBios Corp.
 AnaBios Corp. BiotechnologyHealth Technology AnaBios Corp. engages in the development of medical therapeutics. Its areas of focus include unmet medical need, including cardiac disease and safety, pain, PKD kidney disease, and neurodegeneration. The company was founded by Jack A. Reynolds and Paul E. Miller in 2009 and is headquartered in San Diego, CA. | Biotechnology | Founder | |
| GENELUX CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
DNX Biopharmaceuticals, Inc.
 DNX Biopharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services DNX Biopharmaceuticals, Inc. operates as a biopharmaceuticals company. It develops long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company was founded by John Caputo, Rajiv Datar, and Howard Levine in 2014 and is headquartered in Irvine, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Louisiana State University | College/University | Doctorate Degree | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
DTE Energy Ventures, Inc.
 DTE Energy Ventures, Inc. Investment ManagersFinance DTE Energy Ventures Inc (DTE Energy Ventures) is a venture capital firm founded in 1994. The firm is headquartered in Ann Arbor, Michigan. | Investment Managers | Private Equity Investor | |
| University of Virginia | College/University | Undergraduate Degree | |
| CENTURY THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of Chicago | College/University | Doctorate Degree | |
| University of Illinois College of Law | College/University | Graduate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| COGNITION THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
American Association for the Advancement of Science
 American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Chairman | |
| Augsburg College | College/University | Undergraduate Degree | |
| North Central College | College/University | Undergraduate Degree | |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | Sales & Marketing | |
| TARSUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| Muhlenberg College | College/University | Director/Board Member | |
PatientWisdom, Inc.
 PatientWisdom, Inc. Packaged SoftwareTechnology Services PatientWisdom, Inc. develops and operates platform that collects, curates, segments and shares patient stories. The firm offers services to patients and families, healthcare providers, researchers and educators, and manufacturers and payers. The company was founded by Gregory Makoul and Eric Langshur in 2015 and is headquartered in New Haven, CT. | Packaged Software | Director of Finance/CFO | |
Riverfront Recapture, Inc.
 Riverfront Recapture, Inc. RestaurantsConsumer Services Riverfront Recapture, Inc. operates a non-profit organization. Stroll miles of trails and walkways; fish, boat, or row. Experience teamwork on the challenge course and enjoy the annual River fest celebration, fireworks and free concerts and festivals all season long. The company was founded in 1981 and is headquartered in Hartford, CT. | Restaurants | Director/Board Member | |
| The University of Colorado | College/University | Undergraduate Degree | |
| BOUNDARY GOLD AND COPPER MINING LTD. | Precious Metals | Director of Finance/CFO |
Statistieken
Internationaal
| Verenigde Staten | 38 |
| Verenigd Koninkrijk | 2 |
| Canada | 2 |
Sectoraal
| Consumer Services | 13 |
| Health Technology | 12 |
| Finance | 6 |
| Commercial Services | 4 |
| Producer Manufacturing | 3 |
Operationeel
| Director/Board Member | 77 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 15 |
| Undergraduate Degree | 12 |
| Founder | 12 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter Longo | 30 |
| Jay Flatley | 27 |
| Mark Zhu | 14 |
| Janelle Anderson | 12 |
| Dave Jenkins | 11 |
| Anthony Caggiano | 10 |
| Frank Sciavolino | 9 |
| Matthew Rossen | 9 |
| Thomas Zindrick | 8 |
| Mark Day | 8 |
| Jeffrey P. Draime | 7 |
| Mohendra Moodley | 6 |
| James Linton | 6 |
| Paul R. McGuirk | 6 |
| Thomas Hoxie | 4 |
- Beurs
- Insiders
- Marc F. Pelletier
- Bedrijfsconnecties
